Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

TARA Protara Therapeutics Inc

2,99

0,09 (3,10%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Protara Therapeutics Charts.

Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Protara Therapeutics Charts.

News Protara Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 31 Mai 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 24 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Protara Therapeutics to Present at the TD Cowen 5th Annual Oncology Innovation Summit
Dienstag 21 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 18 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 11 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Freitag 10 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
Donnerstag 2 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing
Freitag 5 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition
Freitag 5 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Protara Therapeutics Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
Freitag 5 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Mittwoch 13 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Protara Therapeutics Inc News-Artikel

Iveda Solutions

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen